Dr. Deyan Liu （Chief Physician）
Share
Dr. Deyan Liu
Chief Physician
Introduction:
-
Committee Member of the Stem Cell Transplantation and Plasma Exchange Group, Chinese Society of Biomedical Engineering
-
Member of the Translational Hematology Committee, Chinese Anti-Cancer Association
Specialization:
-
Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases
-
Treatment of Acute Leukemia, Lymphoma, and Myeloma
Biography
-
With over 18 years of experience in hematology and stem cell transplantation, Dr. Liu has performed more than 900 stem cell transplant procedures, with the oldest patient being 73 and the youngest 1 year old.
-
Dr. Liu specializes in treating various malignant hematological diseases, including acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, and refractory or relapsed lymphomas and myelomas.
-
He has extensive experience in treating non-malignant blood diseases such as severe aplastic anemia and congenital pure red cell aplasia.
-
He pioneered allogeneic stem cell transplantation for rare diseases such as familial hemophagocytic lymphohistiocytosis, Langerhans cell histiocytosis, X-linked chronic granulomatous disease, congenital immunodeficiencies, and congenital keratinization defects with accompanying bone marrow failure.
Academic Focus
-
Dr. Liu’s primary research interests include enhanced conditioning regimens for stem cell transplantation in refractory and relapsed leukemia and lymphoma, as well as the prevention and treatment of severe graft-versus-host disease (GVHD) post-transplantation.
-
He has published numerous articles in journals such as Chinese Journal of Hematology, Clinical Hematology Journal, Leukemia & Lymphoma Journal, Int J Lab Hematol, APBMT, EBMT, and at national hematology conferences.
Summary:
Dr. Liu is a highly skilled hematologist specializing in allogeneic stem cell transplantation. He has performed over 900 transplants and is a recognized expert in treating both malignant and non-malignant hematological diseases. His work has contributed to advancements in stem cell transplantation techniques, especially for challenging cases.